Skip to content
The Policy VaultThe Policy Vault

Treximet (sumatriptan/naproxen)CareFirst (Caremark)

Acute treatment of migraine with or without aura in adults and pediatric patients age ≥ 12 years (Treximet)

Preferred products

  • generic sumatriptan
  • generic naproxen
  • generic meloxicam
  • generic rizatriptan

Initial criteria

  • Diagnosis of migraine headache
  • Patient has tried and experienced an inadequate treatment response or intolerance to THREE triptan 5-HT1 agonists
  • Patient has tried the two individual components of the requested drug taken together [i.e., (meloxicam plus rizatriptan) or (naproxen plus sumatriptan)]

Approval duration

12 months